Accès ouvert
2026
article
OpenAlex
Zhao Wang, Wei Dong, Xiangling Feng, Xinran Xu et autres
expression and aberrant T cell hyperactivation. Our integrative and context-dependent strategy establishes a comprehensive pathway for deciphering the missing regulatory mechanisms of complex disease.
cn, pl, hk
(code pays fourni par la source)
2025
article
OpenAlex
Dalong Zhu, Jianhua Ma, Weimin Wang, Bi‐Min Shi et autres
cn, us
(code pays fourni par la source)
2025
review
OpenAlex
Zeming Wu, Jing Tao Qu, Weiqi Zhang, Zhijun Bao et autres
cn, in, Éthiopie, hk, us, mx
(code pays fourni par la source)
2025
article
OpenAlex
Leili Gao, Linong Ji, Xin Yan, Zhifeng Cheng et autres
AIMS: Chiglitazar is a novel peroxisome proliferator-activated receptor pan-agonist regulating glucose and lipid metabolism. The RECAM study aimed to evaluate the efficacy and safety of chiglitazar add-on therapy to metformin in patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: In …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xiaoqian Luan, Jin Zhou, Jin Li, Yao An et autres
OBJECTIVES: Evidence has shown that both smoking and periodontitis were linked to cognitive impairment. This study examines whether periodontitis mediates the effects of smoking status on cognitive function in older adults. METHODS: Using data from the National Health and Nutrition Examination Survey …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Weihong Song, Xiaomei Jiang, Weiguo Yu, Ziwei Xiang
A Rh( iii )-catalyzed synthesis of unprecedented benzo[ h ]isoquinolin-3-ones from 1-naphthaldehyde, aniline and diazo compounds in one pot has been realized with an imine as the directing group which was generated from aldimine condensation in situ .
cn, cz
(code pays fourni par la source)
2024
article
OpenAlex
Qinghua He, Zhifeng Cheng, Yufeng Li, Xiaoyan Xing et autres
Abstract Aims To assess the efficacy and safety of cofrogliptin for impaired glucose tolerance (IGT). Methods In this multicenter, double‐blind, placebo‐controlled phase 2 trial, IGT patients were randomized 1:1:1 to receive cofrogliptin 10 mg, cofrogliptin 25 mg or placebo once biweekly. The …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Shuai Ma, Zhejun Ji, Bin Zhang, Lingling Geng et autres
cn, in, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Xiaoyong Lu, Ning Liu, Shuai Ma, Hui Zhang et autres
cn, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Mengen Xing, Wanqi Chen, Yachen Ji, Weihong Song
The phenotypic switch of vascular smooth cells (VSMCs) from a contractile to a synthetic state is associated with the development and progression of aortic aneurysm (AA). However, the mechanism underlying this process remains unclear. In this issue of the JCI, Song et …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jie Zhang, Yanshuang Jiang, Xiangjun Dong, Zijun Meng et autres
BACKGROUND: Alpha-lipoic acid (ALA) has a neuroprotective effect on neurodegenerative diseases. In the clinic, ALA can improve cognitive impairments in patients with Alzheimer's disease (AD) and other dementias. Animal studies have confirmed the anti-amyloidosis effect of ALA, but its underlying mechanism remains …
cn
(code pays fourni par la source)
2024
article
OpenAlex
Lin Liu, XIAOXIA SHI, Fei He, Zhifeng Cheng et autres
Introduction and Objective: HS-20094 is a novel dual GIP and GLP-1 receptor agonist. A 4-week POC study was conducted to assess the preliminary efficacy and safety of HS-20094 in patients with type 2 diabetes (T2DM). Methods: This was a randomized, double-blind, placebo-controlled …